RecruitingNCT07603583

The Exploration of the Relationship Between Hypertension and Sleep Apnea Through Heart Rate Variability, and the Subsequent Investigation of Non-pharmacological and Pharmacological Treatments

Sponsor: Kaohsiung Armed Forces General Hospital

Trial Details

Condition	Obstructive Sleep Apnea, Hypertension
Intervention	Polysomnography
Status	Recruiting
Participants	100
Est. Completion	31 Dec 2026
Last Updated	22 May 2026

Primary Outcome

Prediction of OSA Severity Using Heart Rate Variability

Eligibility Criteria

Inclusion Criteria

Inclusion Criteria: * Age 18 to 65 years * Diagnosed hypertension or resistant hypertension * STOP-Bang score ≥3 indicating high risk of obstructive sleep apnea * Willing and able to provide informed consent Exclusion Criteria: * Refusal to undergo HRV monitoring or polysomnography * Unstable medical condition that may interfere with study participation * Inability to comply with study procedures

Trial Sites

Countries

Taiwan

View Registry Entry

Related Analysis

Novel Biomarker Study: Heart Rate Variability to Predict Sleep Apnea Severity in Hypertensive Patients — Implications for Australian Practice

Taiwanese researchers investigate heart rate variability as a potential biomarker for predicting sleep apnea severity in hypertensive patients. This novel approach could revolutionise OSA screening using readily available cardiac monitoring equipment.

Read full article →

This content is for educational purposes for healthcare professionals only and does not constitute clinical advice. Clinical decisions should be based on individual patient assessment, current guidelines, and appropriate specialist consultation. Editorial Standards · Privacy Policy · Terms of Service